Resolve BioSciences GmbH, the Germany and US based molecular cartography technology company, has raised USD 71m in a Series B funding round led by Patient Square Capital LLP, the US based private equity firm, with participation from PS Capital Management, the Germany based family office, EDBI, the Singapore based global investment company, Alafi Capital, the US based venture capital firm, NRW.BANK, the Germany based development bank, and other undisclosed existing investors.
Target – Resolve BioSciences GmbH
Buyer – PS Capital Management GmbH
Buyer – Patient Square Capital LLP
Buyer – EDBI Pte Ltd
Buyer – Alafi Capital
Buyer – NRW.BANK
Buyer – Undisclosed Existing Investors
Seller – Shareholders
